Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $5.5200 (3.56%) ($4.6200 - $8.0000) on Mon. Apr. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 18.63% (three month average) | RSI | 50 | Latest Price | $5.5200(3.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -14% a day on average for past five trading days. | Weekly Trend | SONN declines -33.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) SIL(46%) GDX(34%) IBUY(42%) GDXJ(43%) BOTZ(39%) | Factors Impacting SONN price | SONN will decline at least -9.315% in a week (0% probabilities). UUP(-25%) TIP(-42%) FXI(-30%) CEMB(-42%) XLP(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -9.315% (StdDev 18.63%) | Hourly BBV | 0 () | Intraday Trend | 3.6% | | | |
|
1 - 5 Day Possible Target | $-44.79(-911.41%) | Resistance Level | $12.13 | 5 Day Moving Average | $7.27(-24.07%) | 10 Day Moving Average | $10.13(-45.51%) | 20 Day Moving Average | $12.13(-54.49%) | To recent high | -79.2% | To recent low | 3.6% | Market Cap | $51m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |